Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche has reported that its new LightCycler test for the detection of methicillin-resistant Staphylococcus aureus, or MRSA, is now available with the CE Mark, allowing it to be sold for clinical use in the EU.
Subscribe to our email newsletter
According to Roche, the LightCycler MRSA advanced test is a qualitative in vitro diagnostic test for the direct detection of nasal colonization with MRSA. The test will aid in the prevention and control of MRSA infections in healthcare settings resulting in better patient care, the company noted.
The LightCycler MRSA advanced test is performed on Roche’s LightCycler 2.0 Instrument with nasal swab specimens from patients suspected of colonization, using Roche’s patented real-time polymerase chain reaction technology.
Provided in a convenient, ready-to-use format, and designed for flexible batch sizes, the LightCycler MRSA advanced test ensures safety and productivity of laboratory staff, flexible throughput, and accurate and reliable results, the company added.
Daniel O’Day, head of Roche Molecular Diagnostics, said: “As more guidelines recommend or require aggressive screening, it is important that healthcare professionals have access to fast, reliable products that can help improve medical outcomes. This new test will aid infection control programs, and ultimately result in better patient care.”